BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17237416)

  • 1. Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus.
    Bartholdy C; Kauffmann SØ; Christensen JP; Thomsen AR
    J Immunol; 2007 Feb; 178(3):1662-70. PubMed ID: 17237416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40L expression by CD4
    Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
    Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.
    Andreasen SO; Christensen JE; Marker O; Thomsen AR
    J Immunol; 2000 Apr; 164(7):3689-97. PubMed ID: 10725727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
    Whitmire JK; Flavell RA; Grewal IS; Larsen CP; Pearson TC; Ahmed R
    J Immunol; 1999 Sep; 163(6):3194-201. PubMed ID: 10477587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
    Clouthier DL; Zhou AC; Watts TH
    J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus.
    Chen L; Jay DC; Fairbanks JD; He X; Jensen PE
    J Immunol; 2011 Dec; 187(12):6463-72. PubMed ID: 22084437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
    Suresh M; Gao X; Fischer C; Miller NE; Tewari K
    J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 T cell responses to lymphocytic choriomeningitis virus in early growth response gene 1-deficient mice.
    Singh A; Svaren J; Grayson J; Suresh M
    J Immunol; 2004 Sep; 173(6):3855-62. PubMed ID: 15356133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent.
    Zhang B; Maris CH; Foell J; Whitmire J; Niu L; Song J; Kwon BS; Vella AT; Ahmed R; Jacob J; Mittler RS
    J Clin Invest; 2007 Oct; 117(10):3029-41. PubMed ID: 17853940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
    Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CD4+ T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice.
    Christensen JP; Marker O; Thomsen AR
    Scand J Immunol; 1994 Oct; 40(4):373-82. PubMed ID: 7939408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination.
    Nussbaum AK; Rodriguez-Carreno MP; Benning N; Botten J; Whitton JL
    J Immunol; 2005 Jul; 175(2):1153-60. PubMed ID: 16002717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection.
    Whitmire JK; Slifka MK; Grewal IS; Flavell RA; Ahmed R
    J Virol; 1996 Dec; 70(12):8375-81. PubMed ID: 8970958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus.
    Grujic M; Bartholdy C; Remy M; Pinschewer DD; Christensen JP; Thomsen AR
    J Immunol; 2010 Aug; 185(3):1730-43. PubMed ID: 20601595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
    Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
    J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced CD8 T cell responses through GITR-mediated costimulation resolve chronic viral infection.
    Pascutti MF; Geerman S; Slot E; van Gisbergen KP; Boon L; Arens R; van Lier RA; Wolkers MC; Nolte MA
    PLoS Pathog; 2015 Mar; 11(3):e1004675. PubMed ID: 25738498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections.
    Fuller MJ; Khanolkar A; Tebo AE; Zajac AJ
    J Immunol; 2004 Apr; 172(7):4204-14. PubMed ID: 15034033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.